Leverage these CNS-focused solutions independently to address specific protocol requirements or combine for an end-to-end digital trial optimized for endpoint data accuracy in CNS studies:

eCOA & ELECTRONIC CLINICIAN RATINGS

BLINDED DATA
ANALYTICS

RATER TRAINING & CERTIFICATION

CENTRAL REVIEW

SCIENTIFIC
ADVISORY

With dozens of built-in electronic neurology and psychiatry clinical outcome assessments, our eCOA platform minimizes rater errors by applying internal logic, edit checks, audio/video recording capability, and on-screen guidance to facilitate ensure accurate, reliable COA data.    

A must-have component to any CNS study, Signant’s unique analytics solution blends proprietary algorithms with clinical/statistical interpretation and analysis, helping study teams proactively mitigate data quality risks at all relevant levels of your study. 

Leveraging our direct experience in CNS trials, our experts qualify, train, certify, and recalibrate raters throughout your studies to ensure consistency, accuracy, and standardization. Our technology enables gatekeeping of raters by qualification status to further safeguard study data.   

Access a network of specialized, experienced raters who perform independent reviews of recorded assessments to validate scoring and administration consistency and accuracy, ensuring COA data reliability.

Our unrivaled and highly-experienced team of CNS science and medicine professionals, as well as clinical trial technology and operations experts, actively partner with study teams from launch to closeout to optimize clinical data quality and CNS study outcomes 

Improving CNS Study Outcomes
One Endpoint at a Time

Clinical research investigating novel treatments or therapies for Central Nervous System (CNS) diseases is as complicated and nuanced as are the conditions.

Signant SmartSignals clinical trial solutions and our unrivaled, direct experience in CNS science and clinical medicine help study teams support endpoints by addressing three primary challenges:

CONNECT WITH US

Signant SmartSignals    CNS Trial Solutions

Improve signal detection 

Monitor data integrity of primary outcome measures

Differentiate between placebo and active treatment response 

CONNECT WITH US

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all of Top 20 pharma – have trusted Signant Health solutions for remote and site-based eCOA, eConsent, RTSM, supply chain management, and data quality analytics.  Learn more at  www.signanthealth.com. 

IMPROVE YOUR CNS STUDIES WITH SIGNANT

CNS Trial Solutions

CNS Trial Solution Resources

DOWNLOAD

Signant's Subject Matter Experts

MEET THE EXPERTS

Webinar: Advanced Analytics in CNS Trials

WATCH VIDEO

READY TO GET STARTED?

With technology solutions that address complexities inherent in CNS studies, as well as support from experienced project teams and therapeutic area experts, Signant provides a direct, objective path for improved CNS drug development research outcomes.